Equities

Glucose Health Inc

GLUC:PKC

Glucose Health Inc

Actions
  • Price (USD)0.50
  • Today's Change0.065 / 14.94%
  • Shares traded31.24k
  • 1 Year change+16.35%
  • Beta3.5212
Data delayed at least 15 minutes, as of Apr 24 2024 18:16 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Glucose Health, Inc. specializes in manufacturing soluble fiber enriched beverages, with its first brand, GLUCODOWN, scientifically formulated to be nutritionally appropriate for pre and type-2 diabetics. The Company manufactures and distributes nutritional beverages under the GLUCODOWN registered trademark. Its niche is the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. The Company’s GlucoDown brand predominantly serves diabetic and pre-diabetic consumers, offering a functional beverages choice versus other sugar-free beverages. Its FIBER UP brand serves health-conscious consumers, particularly those 45 and over, offering a ready-to-drink beverage with nutritional benefits. GlucoDown is an iced tea mix beverage infused with soluble fiber, launched in North America. Additionally, the Company is engaged in the development of new products and line extensions within its brand.

  • Revenue in USD (TTM)1.11m
  • Net income in USD-456.46k
  • Incorporated2007
  • Employees2.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Adial Pharmaceuticals Inc0.00-7.00m6.89m4.00--0.6925-----5.83-4.170.002.450.00----0.00-133.76-182.35-174.49-235.45-----------55.500.00------35.14------
Protagenic Therapeutics Inc0.00-5.00m6.96m----1.90-----1.15-1.150.000.82710.00-------80.91-74.49-94.48-92.56-----------9.560.00-------40.64------
Plus Therapeutics Inc (USA)4.91m-13.32m6.97m20.00------1.42-4.51-4.511.57-0.30330.2787----245,650.00-75.54-59.18-210.10-133.04-----271.04-470.45----1.51--2,093.30-5.8934.32--3.77--
AiXin Life International Inc4.09m-2.09m7.00m207.00------1.71-0.0836-0.08360.1636-0.07650.82685.4310.0219,757.49-42.27-16.93---34.5416.2548.13-51.12-36.960.1515------51.0058.0867.18--194.59--
Trevena Inc3.13m-40.29m7.11m23.00------2.27-3.16-3.160.2611-0.44290.073.69--135,869.60-90.25-55.93-110.38-66.3546.56---1,289.25-3,134.414.66-15.431.33--847.61-11.4324.93---24.67--
eFFECTOR Therapeutics Inc0.00-35.81m7.15m14.00---------17.11-17.110.00-1.940.00----0.00-144.34-----------------17.381.43---100.00---58.00------
Lixte Biotechnology Holdings Inc0.00-5.09m7.24m3.00--14.64-----2.77-2.770.001.780.00----0.00-103.09-104.18-111.07-111.05------------0.00------19.41------
Kineta Inc5.44m-14.10m7.34m11.00--2.41--1.35-1.43-1.430.52970.2780.3927----494,727.30-101.57-66.16-318.39-86.61-----258.65-854.74---1,310.250.2011--178.6513.8977.76------
Pulmatrix Inc7.30m-14.12m7.38m22.00--0.41--1.01-3.87-3.872.004.930.1948--6.56331,727.30-37.70-46.91-42.80-58.12-----193.49-238.04----0.00--20.21116.6225.03--104.29--
Pasithea Therapeutics Corp0.00-15.51m7.39m8.00--0.3156-----12.83-13.180.0022.460.00----0.00-43.50---46.44--------------0.00-------32.23------
Glucose Health Inc1.11m-456.46k7.40m2.00--7.81--6.65-0.033-0.0330.08030.0561-----------86.94---153.9547.1940.68-31.99-56.93313.11--0.00--98.3924.9416.87------
TFF Pharmaceuticals Inc733.87k-21.24m7.48m19.00--0.7358--10.20-12.67-12.670.40974.040.0406--2.3738,624.74-117.54-79.57-130.37-83.41-----2,894.69-8,687.66----0.00--48.01--33.13------
Biofrontera Inc34.07m-20.13m7.61m85.00--0.4734--0.2233-15.19-15.1924.303.160.86461.935.42400,858.80-51.08---101.07--48.80---59.08--0.6727-2.710.4489--18.82---3,045.47------
Vaccinex Inc570.00k-20.25m7.86m37.00------13.79-63.98-63.981.23-2.590.0982--1.0015,405.41-348.91-262.29-1,283.74-------3,552.81-4,257.17---59.75----107.27-4.67-2.20---22.20--
Intelligent Bio Solutions Inc2.46m-13.40m7.91m17.00--0.1042--3.21-131.37-131.3720.9126.670.18312.419.09144,726.50-99.96-80.65-157.15-224.8420.90---545.95-948.540.3864--0.1602--187.51367.97-28.00------
Data as of Apr 24 2024. Currency figures normalised to Glucose Health Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.